Elizabeth Horn Prsic, MD
Cards
Appointments
Additional Titles
Director, Adult Inpatient Palliative Care, Internal Medicine
Firm Chief, Medical Oncology
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAppointments
Additional Titles
Director, Adult Inpatient Palliative Care, Internal Medicine
Firm Chief, Medical Oncology
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAppointments
Additional Titles
Director, Adult Inpatient Palliative Care, Internal Medicine
Firm Chief, Medical Oncology
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAbout
Titles
Assistant Professor
Director, Adult Inpatient Palliative Care, Internal Medicine; Firm Chief, Medical Oncology
Biography
Dr. Elizabeth Prsic is a physician specializing in medical oncology and palliative care. She received her medical degree from the George Washington School of Medicine. She completed internal medicine residency and medical oncology fellowship at Brown University. Dr. Prsic received a T32 NIH Ruth L. Kirschstein National Research Service award and completed a research fellowship through the Division of Hematology Oncology at Brown University where she focused on end-of-life and palliative care. During research fellowship, she studied cancer epidemiology, biostatistics and health policy at the Brown University School of Public Health.
Dr. Prsic is an assistant professor at Yale Medical School and serves as an attending physician at the Smilow Cancer Hospital and Yale New Haven Hospital. Her research interests include end-of-life care, health care utilization, and symptom management among oncology patients. She is passionate about supporting patients with advanced cancer and their caregivers. Dr. Prsic is dedicated to serving patients with serious or life-limiting illness with complex medical needs or difficult-to-control symptoms. She is committed to medical education and academic mentorship.
Appointments
Medical Oncology
Assistant ProfessorPrimary
Other Departments & Organizations
- Cancer Prevention and Control
- Internal Medicine
- Medical Oncology
- Palliative and End-of-Life Care Education
- Palliative Care Program
- Slayman House Affiliates
- Yale Cancer Center
- Yale Medicine
Education & Training
- Fellowship in Palliative Medicine
- University of Washington
- Fellowship in Medical Oncology
- Brown University
- Residency
- Brown University
- Internship
- Brown University
- MD
- George Washington University School of Medicine
- BA
- Tulane University
Research
Overview
Medical Research Interests
Public Health Interests
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Jensa Morris, MD
Maureen Canavan, PhD, MPH
Jennifer Kapo, MD
Kerin Adelson, MD
Bonnie E Gould Rothberg, MD, PhD, MPH, MMM, FACP
Cary Gross, MD
Medical Oncology
Publications
2024
Multi-day vs single-day dexamethasone for the prophylaxis of chemotherapy-induced nausea and vomiting: systematic review and meta-analysis
Chow R, Celio L, Im J, Caini S, Eng L, Prsic E, Scotté F, Aapro M. Multi-day vs single-day dexamethasone for the prophylaxis of chemotherapy-induced nausea and vomiting: systematic review and meta-analysis. Supportive Care In Cancer 2024, 32: 736. PMID: 39432169, DOI: 10.1007/s00520-024-08934-0.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsDexamethasone-sparing regimenChemotherapy-induced nausea and vomitingModerately emetogenic chemotherapyHighly emetogenic chemotherapyRandomized controlled trialsComplete responseMeta-analysisEmetogenic chemotherapyNo vomitingRescue medicationProphylaxis of chemotherapy-induced nausea and vomitingSystematic reviewSchedule of dexamethasoneNausea and vomitingChemotherapy-induced nauseaResultsTen trialsAntiemetic regimenCumulative meta-analysisEffect estimatesSafety profileComprehensive systematic reviewMethodsOvid MEDLINERegimensAdult cancer patientsCancer patientsGeneral versus disease-specific medical oncology consults and impact on inpatient quality of care.
Prsic E, Deshpande H, Wei W, Strait M, Chiang A. General versus disease-specific medical oncology consults and impact on inpatient quality of care. Journal Of Clinical Oncology 2024, 20: 321-321. DOI: 10.1200/op.2024.20.10_suppl.321.Peer-Reviewed Original ResearchConceptsAdvanced practice providersInpatient qualityPost-interventionOncology consultationICU rateEmergency departmentInpatient quality of careQuality of careHospice referral ratesMedical oncology consultationHospice referralOutpatient productionPractice providersLevel of satisfactionClinician satisfactionConsultative carePre-interventionReferral ratesED visitsSurveys pre-Clinician experienceGeneral consultationVisit dataConsultation modelReadmission ratesTrends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer
Jain S, Long J, Rao V, Law A, Walkey A, Prsic E, Lindenauer P, Krumholz H, Gross C. Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer. Journal Of The American Geriatrics Society 2024 PMID: 39090970, DOI: 10.1111/jgs.19119.Peer-Reviewed Original ResearchCitationsAltmetricConceptsEnd-of-life hospitalizationsLife-sustaining treatmentEnd-of-lifeIntensity of careIn-hospital deathOlder adultsIntensive care unitAdvanced cancerRisk-adjusted hospitalEvaluate trendsIncreased intensity of careIntensive care unit useSEER-Medicare dataIntensive care unit careMultinomial regression modelsYear of diagnosisIntensive careHospital categoryMedicare beneficiariesSEER-MedicareHospitalization ratesCareCancer characteristicsNoninvasive ventilationHospitalA medical school curriculum to foster the physician-patient relationship through narrative medicine.
Yao J, Hunter C, Jaber Chehayeb R, Sanft T, Prsic E, Dunne D, Kang-Giaimo A. A medical school curriculum to foster the physician-patient relationship through narrative medicine. Journal Of Clinical Oncology 2024, 42: e21015-e21015. DOI: 10.1200/jco.2024.42.16_suppl.e21015.Peer-Reviewed Original ResearchConceptsDoctor-patient relationshipPatient storiesNarrative medicineTraining sessionsStrong doctor-patient relationshipOptimal quality careThird-year medical studentsPhysician-patient relationshipMedical school curriculumYear medical studentsImprove well-beingMedical education toolThematic analysis of responsesNarrative medicine curriculumDoctor patient relationshipPre-clerkship studentsMedicine skillsYale School of MedicineQuality careMedical students' senseMedicine curriculumPatient relationshipThematic analysisInterviewed patientsSchool of MedicineAssociation of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer
Maduka R, Canavan M, Walters S, Ermer T, Zhan P, Kaminski M, Li A, Pichert M, Salazar M, Prsic E, Boffa D. Association of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer. Cancer Medicine 2024, 13: e7028. PMID: 38711364, PMCID: PMC11074703, DOI: 10.1002/cam4.7028.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsOptimal quality of careQuality of carePatient socioeconomic statusAssociated with improved qualityAssociated with improved quality of lifeEnd-of-lifeUS cancer populationPalliative treatmentQuality of lifeCox proportional hazards modelsMultivariate logistic regressionInformed decision makingProportional hazards modelFacility characteristicsNon-HispanicAssociated with lower ratesInsurance payer statusImproving informed decision makingCancer populationSocioeconomic statusHispanic ethnicityTreatment usePayer statusBlack raceLogistic regressionImmunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
Kerekes D, Frey A, Prsic E, Tran T, Clune J, Sznol M, Kluger H, Forman H, Becher R, Olino K, Khan S. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. JAMA Oncology 2024, 10: 342-351. PMID: 38175659, PMCID: PMC10767643, DOI: 10.1001/jamaoncol.2023.6025.Peer-Reviewed Original ResearchCitationsAltmetricConceptsNon-small cell lung cancerEnd of lifeMonth of deathImmunotherapy initiationCohort studyMAIN OUTCOMEStage IV non-small cell lung cancerCharlson-Deyo comorbidity indexHigh metastatic burdenInitiation of immunotherapyNational prescribing patternsRisk-adjusted patientsImmune checkpoint inhibitorsRetrospective cohort studyStage IV melanomaPercentage of patientsHigh-volume centersLocation of metastasesLow-volume centersOdds of deathCell lung cancerNational Clinical DatabaseLow-volume facilitiesDrug Administration approvalCheckpoint inhibitors
2023
Oncology hospitalist impact on hospice utilization
Prsic E, Morris J, Adelson K, Parker N, Gombos E, Kottarathara M, Novosel M, Castillo L, Rothberg BE. Oncology hospitalist impact on hospice utilization. Cancer 2023, 129: 3797-3804. PMID: 37706601, DOI: 10.1002/cncr.35008.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMedical oncology serviceOncology servicesEnd of lifeAdvanced cancerInpatient hospiceHospice utilizationHigher total health care costsTotal health care costsComfort-focused careInpatient oncology serviceSmilow Cancer HospitalAdjusted odds ratioLength of staySolid tumor malignanciesLong-term survivalMultivariable linear regressionHealth care costsElectronic medical recordsHospice transitionUnplanned hospitalizationDischarge dispositionHospice referralInpatient managementLate referralCancer HospitalPrevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)—a systematic review and individual patient data meta-analysis
Chow R, Yin L, Baqri W, Huang R, Boldt G, Younus J, Lock M, Prsic E, Zimmermann C, Herrstedt J. Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)—a systematic review and individual patient data meta-analysis. Supportive Care In Cancer 2023, 31: 505. PMID: 37535218, DOI: 10.1007/s00520-023-07978-y.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsChemotherapy-induced nauseaIndividual patient dataDay 4Individual patient-level dataPatient dataPatient-level dataStepwise logistic regressionEmetogenic chemotherapyChemotherapy regimenChemotherapy regimensPatient demographicsCochrane CENTRALResultsA totalOverall prevalenceCINVNauseaVomitingPatientsEligible articlesSystematic reviewAntineoplastic agentsStudy authorsLogistic regressionMethodsThis reviewSignificant riskAdvance care planning and hospital outcomes in solid tumour oncology inpatients
Qeska D, Chow R, Balboni T, Kapo J, Zimmermann C, Prsic E. Advance care planning and hospital outcomes in solid tumour oncology inpatients. BMJ Supportive & Palliative Care 2023, 14: e541-e544. PMID: 37500567, DOI: 10.1136/spcare-2023-004396.Peer-Reviewed Original ResearchAltmetricConceptsAdvance care planningHospital mortalityED visitsEmergency departmentCare planningYale-New Haven HospitalObservational cohort analysisIntensive care unitMultivariable logistic regressionSolid tumor malignanciesNew Haven HospitalDecreased readmissionsHospital outcomesOncology inpatientsPatient characteristicsACP documentationHospital readmissionLonger LOSCare unitOncology careRothman IndexCohort analysisPatientsTumor malignancyInpatient teamsThe impact of oncology hospitalist utilization on resident education.
Bhatt S, Yao J, Gould Rothberg BE, Morris J, Parker N, Adelson K, Prsic E. The impact of oncology hospitalist utilization on resident education. Journal Of Clinical Oncology 2023, 41: 11034-11034. DOI: 10.1200/jco.2023.41.16_suppl.11034.Peer-Reviewed Original ResearchConceptsHospitalist serviceMedical oncologistsCancer CenterPercent of residentsU.S. cancer centersMann-Whitney U testGOC discussionsMedical oncologyCare discussionsInpatient teaching servicesOutpatient careInpatient careEligible residentsPatient careUniversity IRBFamily meetingsHospitalistsU testOncologistsStatistical significanceStudy intervalTwo-week periodCareP-valueFive-point Likert scale
Academic Achievements & Community Involvement
activity New England Journal of Medicine - Journal Watch
Journal ServiceGuest EditorDetailsGuest Editor for Palliative Care and Supportive Oncology2023 - Presentactivity National Comprehensive Cancer Network
Professional OrganizationsCommittee MemberDetailsSupportive Care Guidelines, Adult Cancer Pain2022 - Presenthonor Patient Experience Award for Caring and Excellence
Hospital System AwardYale New Haven HospitalDetails12/01/2023activity Cancer Medicine
Journal ServiceAssociate EditorDetails2022 - 2023honor Smilow Luminary Award
Hospital System AwardSmilow Cancer HospitalDetails10/01/2020United States
Clinical Care
Overview
Elizabeth Prsic, MD, is a medical oncologist and palliative medicine physician who specializes in the inpatient care of patients with advanced cancer. She works with an interdisciplinary team to help support patients who are facing serious illness and their caregivers.
Dr. Prsic’s research interests include end-of-life care, health care utilization, symptom management, and supportive care for patients with advanced cancer. She earned her medical degree from the George Washington University School of Medicine. She completed her internal medicine internship, residency, and medical oncology fellowship at Brown University’s Warren Alpert Medical School, where she also completed a National Institutes of Health-funded research fellowship focusing on end-of-life care. She completed her hospice and palliative medicine fellowship at the University of Washington.
She is an assistant professor at Yale School of Medicine, and serves as the firm chief for medical oncology and the director of Adult Inpatient Palliative Care.
Clinical Specialties
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
- December 17, 2024
YCC Publications 2024
- April 26, 2024
Gastrointestinal Cancer CME Series
- April 24, 2024Source: MedScape
How These Young MDs Impressed the Hell Out of Their Bosses
- March 27, 2024Source: Hospice News
Hospitalists More Likely than Specialists to Refer to Hospice